We are live on ! Find out more
MATK

MARTEK BIOSCIENCES CORP
MATK

Delisted

MATK was delisted on the 25th of February, 2011.

Back to rankings

1 hedge funds and large institutions have $133K invested in MARTEK BIOSCIENCES CORP in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SBL
1
Sargent Bickham Lagudis
Colorado
$133K +$133K +3,930 New

MATK Hedge Fund Activity: Q1 2016 in Review

1 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in MARTEK BIOSCIENCES CORP (MATK) for Q1 2016, worth a combined $133K.

Buyers outnumbered sellers: 1 fund opened new MATK positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held MARTEK BIOSCIENCES CORP (MATK) as of Q1 2016, up from 0 in Q4 2015.
  • Funds reported $133K of MARTEK BIOSCIENCES CORP stock for Q1 2016.
  • 1 fund opened new MARTEK BIOSCIENCES CORP positions in Q1 2016 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q1 2016.